Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-Human CD257 (BAFF) (Tabalumab)

Expression Host : HEK-293 Pathogen Testing : To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of this recombinant biosimilar antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile. This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Tabalumab. Tabalumab neutralizes soluble human, cynomolgus monkey, and rabbit BAFF. Additionally, Tabalumab neutralizes membrane-bound BAFF. This product is for research use only. Tabalumab is a human monoclonal anti-B-cell activating factor (BAFF) antibody intended for the treatment of autoimmune diseases and B cell malignancies.1 BAFF is a membrane-bound, type II transmembrane protein that belongs to the tumor necrosis factor (TNF) ligand family and is the ligand for BR3, TACI, and BCMA. BAFF is an immunostimulant necessary for maintaining normal immunity. This cytokine has also been shown to play an important role in the proliferation and differentiation of B cells. An inadequate level of BAFF leads to immunodeficiency whilst an elevated level of BAFF causes unusually high antibody production that results in the development of autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. Additionally, BAFF has been found in renal transplant biopsies with acute rejection.2 Furthermore, BAFF may be a mediator of food-related inflammation, and is associated with multiple dietary ailments including celiac disease, insulin resistance, diabetes, and obesity.3 Interestingly, it is suspected that BAFF may be involved in non-IgE-mediated reactions because there is no known correlation between BAFF and IgE.4 More research is needed to unlock the enormous therapeutic potential for BAFF antagonists. This cost-effective, research-grade Anti-Human CD257 (BAFF) (Tabalumab) utilizes the same variable regions from the therapeutic antibody Tabalumab making it ideal for research projects.

Product Specifications

Product Name Alternative

DTL; BLYS; TALL1; THANK; ZTNF4; TALL-1; TNLG7A; TNFSF20; TNFSF13B

Host

Human

Immunogen

Original antibody was raised against soluble human BAFF.

Target Antigen

BAFF

Clonality

Monoclonal

Clone

Tabalumab

Applications

ELISA

Purification

>=95% monomer by analytical SEC

Components

Concentration : >= 5.0 mg/mlThis biosimilar antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.

Storage Conditions

Functional grade biosimilar antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

Applications Notes

Endotoxin : <= 1.0 EU/mg as determined by the LAL method The suggested concentration for Tabalumab biosimilar antibody for staining cells in flow cytometry is <= 0.25 μg per 106 cells in a volume of 100 μl. Titration of the reagent is recommended for optimal performance for each application.

Isotype

Human IgG1k

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Mouse Adra2c Pre-designed siRNA Set A
SI100353A 1 Each

Mouse Adra2c Pre-designed siRNA Set A

Ask
View Details
ENO2 Monoclonal Antibody
MBS7135143-01 0.05 mg

ENO2 Monoclonal Antibody

Ask
View Details
ENO2 Monoclonal Antibody
MBS7135143-02 0.1 mg

ENO2 Monoclonal Antibody

Ask
View Details
ENO2 Monoclonal Antibody
MBS7135143-03 5x 0.1 mg

ENO2 Monoclonal Antibody

Ask
View Details
Recombinant Pseudomonas aeruginosa Dihydrodipicolinate reductase (dapB)
MBS1247177-01 0.02 mg (E-Coli)

Recombinant Pseudomonas aeruginosa Dihydrodipicolinate reductase (dapB)

Ask
View Details
Recombinant Pseudomonas aeruginosa Dihydrodipicolinate reductase (dapB)
MBS1247177-02 0.02 mg (Yeast)

Recombinant Pseudomonas aeruginosa Dihydrodipicolinate reductase (dapB)

Ask
View Details